BACHY vs. BSX
BACHY (Bank of China Ltd ADR) and BSX (Boston Scientific Corporation) are both stocks. BACHY operates in Banks - Diversified (Financial Services), while BSX operates in Medical Devices (Healthcare). Over the past 10 years, BACHY returned 13.27%/yr vs 7.66%/yr for BSX. At a 0.24 correlation, their price movements are largely independent.
Performance
BACHY vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BACHY achieves a 17.86% return, which is significantly higher than BSX's -49.99% return. Over the past 10 years, BACHY has outperformed BSX with an annualized return of 13.27%, while BSX has yielded a comparatively lower 7.66% annualized return.
BACHY
- 1D
- 1.51%
- 1M
- 3.82%
- YTD
- 17.86%
- 6M
- 15.07%
- 1Y
- 20.61%
- 3Y*
- 29.74%
- 5Y*
- 20.81%
- 10Y*
- 13.27%
BSX
- 1D
- -0.63%
- 1M
- -15.61%
- YTD
- -49.99%
- 6M
- -51.85%
- 1Y
- -54.23%
- 3Y*
- -2.74%
- 5Y*
- 2.89%
- 10Y*
- 7.66%
BACHY vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BACHY Bank of China Ltd ADR | 17.86% | 23.87% | 43.09% | 14.58% | 10.54% | 14.31% | -14.46% | 4.65% | -8.11% | 15.60% |
BSX Boston Scientific Corporation | -49.99% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between BACHY and BSX is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Apr 27, 2009 | 0.24 |
Over the past year, the correlation between BACHY and BSX has dropped to 0.02 - well below their long-term average of 0.24, suggesting their price drivers have been diverging.
Fundamentals
BACHY:
$198.18B
BSX:
$71.28B
BACHY:
$19.38
BSX:
$2.38
BACHY:
0.87
BSX:
20.06
BACHY:
0.72
BSX:
0.45
BACHY:
0.17
BSX:
3.46
BACHY:
0.07
BSX:
2.76
BACHY:
$1.22T
BSX:
$20.62B
BACHY:
$635.71B
BSX:
$14.52B
BACHY:
$307.28B
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BACHY vs. BSX — Risk / Return Rank
BACHY
BSX
BACHY vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bank of China Ltd ADR (BACHY) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BACHY | BSX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.21 | -1.57 | +2.78 |
Sortino ratioReturn per unit of downside risk | 1.88 | -2.40 | +4.28 |
Omega ratioGain probability vs. loss probability | 1.21 | 0.65 | +0.56 |
Calmar ratioReturn relative to maximum drawdown | 1.42 | -0.98 | +2.40 |
Martin ratioReturn relative to average drawdown | 4.10 | -2.25 | +6.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BACHY | BSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.21 | -1.57 | +2.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.07 | 0.11 | +0.95 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.65 | 0.28 | +0.36 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.41 | 0.19 | +0.22 |
Drawdowns
BACHY vs. BSX - Drawdown Comparison
The maximum BACHY drawdown since its inception was -53.68%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for BACHY and BSX.
Loading charts...
Drawdown Indicators
| BACHY | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.68% | -89.15% | +35.47% |
Max Drawdown (1Y)Largest decline over 1 year | -13.43% | -55.91% | +42.48% |
Max Drawdown (3Y)Largest decline over 3 years | -15.70% | -55.91% | +40.21% |
Max Drawdown (5Y)Largest decline over 5 years | -16.91% | -55.91% | +39.00% |
Max Drawdown (10Y)Largest decline over 10 years | -40.98% | -55.91% | +14.93% |
Current DrawdownCurrent decline from peak | 0.00% | -55.91% | +55.91% |
Average DrawdownAverage peak-to-trough decline | -19.89% | -38.75% | +18.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.65% | 24.31% | -19.66% |
Volatility
BACHY vs. BSX - Volatility Comparison
The current volatility for Bank of China Ltd ADR (BACHY) is 4.52%, while Boston Scientific Corporation (BSX) has a volatility of 16.24%. This indicates that BACHY experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BACHY | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.52% | 16.24% | -11.72% |
Volatility (6M)Calculated over the trailing 6-month period | 12.56% | 32.81% | -20.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.18% | 34.64% | -17.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.61% | 25.66% | -6.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.62% | 27.29% | -6.67% |
Dividends
BACHY vs. BSX - Dividend Comparison
BACHY's dividend yield for the trailing twelve months is around 2.28%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BACHY Bank of China Ltd ADR | 2.28% | 8.52% | 6.46% | 8.92% | 9.64% | 8.57% | 7.99% | 5.32% | 5.42% | 4.08% | 11.53% | 7.39% |
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BACHY vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Bank of China Ltd ADR and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BACHY vs. BSX - Profitability Comparison
BACHY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bank of China Ltd ADR reported a gross profit of 143.17B and revenue of 311.94B. Therefore, the gross margin over that period was 45.9%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
BACHY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bank of China Ltd ADR reported an operating income of 74.31B and revenue of 311.94B, resulting in an operating margin of 23.8%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
BACHY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bank of China Ltd ADR reported a net income of 56.29B and revenue of 311.94B, resulting in a net margin of 18.0%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
BACHY and BSX have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BSX has higher volatility (16.24%) compared to BACHY (4.52%). In terms of maximum drawdown, BACHY dropped -53.68% vs BSX's -89.15%.
BACHY currently has the higher Sharpe Ratio (1.21 vs -1.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BACHY and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer